sr141716 has been researched along with Retinal Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Imamura, T; Inoue, Y; Ogami, S; Ohno, Y; Otsuka, T; Shimazawa, M; Tsuruma, K; Yamane, S | 1 |
| Chen, Y; Liu, S; Luo, X; Shen, Y | 1 |
2 other study(ies) available for sr141716 and Retinal Degeneration
| Article | Year |
|---|---|
Rimonabant, a selective cannabinoid
Topics: Animals; Cannabinoid Receptor Antagonists; Cell Death; Cell Line; Gene Expression Regulation; Light; Male; Mice; Piperidines; Pyrazoles; Receptors, Cannabinoid; Retinal Cone Photoreceptor Cells; Retinal Degeneration; Rimonabant | 2017 |
Neuroprotective effect of cannabinoid receptor 1 antagonist in the MNU-induced retinal degeneration model.
Topics: Alkylating Agents; Animals; Biomarkers; Blotting, Western; Cannabinoid Receptor Antagonists; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Methylnitrosourea; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Patch-Clamp Techniques; Photoreceptor Cells, Vertebrate; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Retina; Retinal Degeneration; Rimonabant | 2018 |